Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Development of Immunocompetence

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Humoral Immune Responses

Humoral Immune Responses

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Endobronchial Schwannoma Presenting as Persistent Cough: Diagnosis and Successful Bronchoscopic Resection.

Cureus·2026

Same author

Severe Diabetic Ketoacidosis With Fatal Cerebral Edema in an Adult.

Cureus·2026

Same author

Diffuse Alveolar Hemorrhage Leading to Respiratory Failure in Mixed Phenotype Acute Leukemia: A Fatal Pulmonary Complication.

Cureus·2025

Same author

A Rare Presentation of Acute Generalized Exanthematous Pustulosis With Refractory Shock.

Cureus·2025

Same author

Synergistic Drug-Induced Diffuse Alveolar Hemorrhage in a Polysubstance User: A Case of Inhaled Cocaine and Fentanyl Toxicity.

Cureus·2025

Same author

In-depth analysis of a mixed Mycobacterium tuberculosis infection involving a multidrug-resistant strain and a susceptible strain.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020

Search research articles

Related Experiment Video

Updated: May 16, 2026

Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens

Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens

Published on: September 20, 2024

Immuno compromised patients: what a challenge!

Madeleine Gutiérrez-Acevedo¹, Carmen R Balleste-Frank, Francisco Fernández-González

¹Internal Medicine Department, San Juan City Hospital, PMB # 79 PO Box 7034, San Juan, Puerto Rico 00936-8344. maicy05@yahoo.com

Boletin De La Asociacion Medica De Puerto Rico

|November 20, 2012

Summary

Mucormycosis is a rare, fatal fungal infection. This case highlights a lung mucormycosis infection in an immunocompromised patient resistant to standard treatments.

More Related Videos

Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis (EAE) Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge

Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis (EAE) Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge

Published on: April 9, 2012

Related Experiment Videos

Last Updated: May 16, 2026

Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens

Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens

Published on: September 20, 2024

Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis (EAE) Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge

Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis (EAE) Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge

Published on: April 9, 2012

Area of Science:

Mycology
Infectious Diseases
Pulmonology

Background:

Mucormycosis is a severe, life-threatening fungal infection.
It primarily affects immunocompromised individuals, including those with diabetes, malignancy, undergoing transplantation, or with renal insufficiency.
Airborne transmission is the usual route of infection.

Observation:

The study reviews a case of an immunocompromised patient.
The patient presented with lung mucormycosis.
The infection was unresponsive to broad-spectrum antibiotics and conventional antifungal therapies.

Findings:

This case illustrates a challenging presentation of lung mucormycosis.
The patient's condition did not improve with standard treatments, indicating potential resistance or atypical disease progression.
The review focuses on the diagnostic and therapeutic challenges in such cases.

Implications:

This case underscores the need for heightened awareness of mucormycosis in immunocompromised patients.
It suggests that conventional therapies may not always be effective, necessitating exploration of alternative or novel treatment strategies.
Further research into the management of refractory mucormycosis is warranted to improve patient outcomes.